Opioid Suits Loom Over A Walgreens-AmerisourceBergen Deal

AmerisourceBergen’s potential exposure in opioid-related litigation figures in Walgreens Boots Alliance potential acquisition of the drug distributor.

Read the full post on Forbes - Healthcare

Bruce Japsen, Contributor